Lundgren, Per-Olof; Tribukait, Bernhard; Kjellman, Anders et. al 2022 Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer Research article (Peer reviewed) DOI:10.1002/pros.24335
Saellstrom, S.; Sharif, H.; Jagarlamudi, K. K. et. al 2022 Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies Research article (Peer reviewed) DOI:10.1016/j.rvsc.2022.02.019
Jagarlamudi, Kiran Kumar; Zupan, Mojca; Kumer, Kristina et. al 2019 The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate-specific antigen density can improve the ability to differentiate prostate cancer from noncancerous conditions Research article (Peer reviewed) DOI:10.1002/pros.23791
Jagarlamudi, K. K.; Wang, L.; Eriksson, S. 2018 Doxorubicin effects on leukemia and breast cancer cells in culture on the TK1 protein levels using AroCell TK 210 ELISA: a tool for drug development Research article (Peer reviewed) DOI:10.1080/15257770.2018.1478094
Jagarlamudi, Kiran Kumar; Shaw, Martin 2018 Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker Review article (Peer reviewed) DOI:10.2217/bmm-2018-0157
Kumar, J. Kiran; Aronsson, A. C.; Pilko, G. et. al 2016 A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease Research article (Peer reviewed) DOI:10.1007/s13277-016-5024-z
Jagarlamudi, Kiran Kumar 2015 Diagnostic implications of the molecular forms and levels of serum thymidine kinase 1 in different canine malignancies Doctoral thesis
Jagarlamudi, Kiran Kumar; Moreau, Laura; Westberg, Sara et. al 2015 A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management Research article (Peer reviewed) DOI:10.1371/journal.pone.0137871
Jagarlamudi, Kiran Kumar; Hansson, Lars Olof; Eriksson, Staffan 2015 Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker Research article (Peer reviewed) DOI:10.1186/s12885-015-1073-8
Kumar, K. J.; Aronsson, A. C.; Pilko, G. et. al 2014 The new TK 201 ELISA provides prognostic information in patients with breast cancer Conference abstract
Jagarlamudi KK, Westberg S, Ronnberg H, Eriksson S 2014 Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker Research article (Peer reviewed) DOI:10.1186/s12917-014-0228-1
Jagarlamudi, Kiran Kumar; Sharif, Hanan; Westberg, Sara et. al 2013 High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: Implications for in vitro diagnostics Research article (Peer reviewed) DOI:10.1016/j.tvjl.2013.05.036
Jagarlamudi, K-K; Sharif, H.; von Euler, S. H. et. al 2012 The increase in serum thymidine kinase 1 subunit levels is more significant than the TK1-activities in samples from patients with solid tumors; implications for disease detection and monitoring efficiency Conference abstract (Peer reviewed)
Sharif, Hanan; Jagarlamudi, Kiran Kumar; Wang, Liya et. al 2012 Quaternary Structures of Recombinant, Cellular and Serum Forms of Thymidine Kinase 1 from Dogs and Humans Research article (Peer reviewed) DOI:10.1186/1471-2091-13-12